HIMS

Hims & Hers Health, Inc.

There isn't enough reported data to score HIMS yet.

SIGA

SIGA Technologies, Inc.

21
Fundamentals7/ 100
Valuation5/ 100
Upside potential5/ 100
Risk potential98/ 100

SIGA's fundamentals are weak and it looks expensive: trading at 289x earnings, about 30 times its usual 9.6x. Its downside scenario is more than ten times its upside.

HIMS Fundamentals

MetricStatus
Strong
Weak
Stable
Strong

HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.

SIGA Fundamentals

MetricStatus
Weak
Under pressure
Weak
Strong

SIGA's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.

HIMS PE Valuation

HIMS has no meaningful PE right now: it lost money over the past year.

SIGA PE Valuation

CHEAPFAIREXPENSIVE75x150x225x301x
CHEAPFAIREXPENSIVE75x150x225x301x
LevelPEPriceVs current
Cheap6.4x$0.06-98%
Fair9.5x$0.10-97%
Expensive16x$0.16-94%
Current289x$2.89โ€”

Historical ranges are pointers, not guarantees.

SIGA's PE is in its expensive range at 289x.

HIMS Forward outlook

MetricOutlook
--
Turning to a loss
Strong growth
Stable
Limited
Low

Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.

SIGA Forward outlook

There aren't enough analyst estimates for SIGA to show an outlook.

HIMS Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $19.73 on Nov 12.

There is not enough scenario data to compare HIMS and SIGA's risk to reward.

SIGA Risk to reward

ScenarioChangePrice
Upside+6%$3.05
Downside-98%$0.07

Calculated from the latest close: $2.89 on Nov 12.

There is not enough scenario data to compare HIMS and SIGA's risk to reward.

HIMS Earnings Per Share

Q4 2023: $-0.11Q1 2024: $-0.01Q2 2024: $0.08Q3 2024: $0.44Q4 2024: $0.53Q1 2025: $0.68Q2 2025: $0.79Q3 2025: $0.53Q4 2025: $0.51Q1 2026: $-0.09Q2 2026: $-0.63Q3 2026: $-0.83
Q4 2023: $-0.11Q1 2024: $-0.01Q2 2024: $0.08Q3 2024: $0.44Q4 2024: $0.53Q1 2025: $0.68Q2 2025: $0.79Q3 2025: $0.53Q4 2025: $0.51Q1 2026: $-0.09Q2 2026: $-0.63Q3 2026: $-0.83
QuarterTTM EPSYoY
Q3 2026-$0.83-257%
Q2 2026-$0.63-180%
Q1 2026-$0.09-113%
Q4 2025$0.51-3.8%
Q3 2025$0.53+20%
Q2 2025$0.79+888%
Q1 2025$0.68+$0.69
Q4 2024$0.53+$0.64

HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.

SIGA Earnings Per Share

Q4 2023: $0.95Q1 2024: $1.10Q2 2024: $1.17Q3 2024: $1.20Q4 2024: $0.82Q1 2025: $0.67Q2 2025: $1.13Q3 2025: $1.02Q4 2025: $0.32Q1 2026: $0.28Q2 2026: $-0.04Q3 2026: $0.01
Q4 2023: $0.95Q1 2024: $1.10Q2 2024: $1.17Q3 2024: $1.20Q4 2024: $0.82Q1 2025: $0.67Q2 2025: $1.13Q3 2025: $1.02Q4 2025: $0.32Q1 2026: $0.28Q2 2026: $-0.04Q3 2026: $0.01
QuarterTTM EPSYoY
Q3 2026$0.01-99%
Q2 2026-$0.04-104%
Q1 2026$0.28-58%
Q4 2025$0.32-61%
Q3 2025$1.02-15%
Q2 2025$1.13-3.4%
Q1 2025$0.67-39%
Q4 2024$0.82-14%

SIGA has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.

HIMS Quarterly Revenue

Q4 2023: $247MQ1 2024: $278MQ2 2024: $316MQ3 2024: $402MQ4 2024: $481MQ1 2025: $586MQ2 2025: $545MQ3 2025: $599MQ4 2025: $618MQ1 2026: $608MQ2 2026: $753MQ3 2026: $890M
Q4 2023: $247MQ1 2024: $278MQ2 2024: $316MQ3 2024: $402MQ4 2024: $481MQ1 2025: $586MQ2 2025: $545MQ3 2025: $599MQ4 2025: $618MQ1 2026: $608MQ2 2026: $753MQ3 2026: $890M
QuarterRevenueYoY
Q3 2026$890.4M+49%
Q2 2026$753.2M+38%
Q1 2026$608.1M+3.8%
Q4 2025$617.8M+28%
Q3 2025$599M+49%
Q2 2025$544.8M+73%
Q1 2025$586M+111%
Q4 2024$481.1M+95%

HIMS has the edge over SIGA on sales, with more consistent year-over-year improvement.

SIGA Quarterly Revenue

Q4 2023: $116MQ1 2024: $25MQ2 2024: $22MQ3 2024: $10MQ4 2024: $81MQ1 2025: $7MQ2 2025: $81MQ3 2025: $3MQ4 2025: $4MQ1 2026: $6MQ2 2026: $41MQ3 2026: $1M
Q4 2023: $116MQ1 2024: $25MQ2 2024: $22MQ3 2024: $10MQ4 2024: $81MQ1 2025: $7MQ2 2025: $81MQ3 2025: $3MQ4 2025: $4MQ1 2026: $6MQ2 2026: $41MQ3 2026: $1M
QuarterRevenueYoY
Q3 2026$1.3M-50%
Q2 2026$41M-49%
Q1 2026$6.2M-11%
Q4 2025$3.8M-95%
Q3 2025$2.6M-74%
Q2 2025$81.1M+272%
Q1 2025$7M-72%
Q4 2024$81.5M-30%

SIGA's revenue has slid since its 2023 peak: $1M last quarter, down 50% from the same quarter a year ago.

HIMS Free Cash Flow

Q4 2023: $22MQ1 2024: $26MQ2 2024: $54MQ3 2024: $85MQ4 2024: --Q1 2025: $50MQ2 2025: โˆ’$70MQ3 2025: $79MQ4 2025: โˆ’$3MQ1 2026: $53MQ2 2026: โˆ’$68MQ3 2026: $26M
Q4 2023: $22MQ1 2024: $26MQ2 2024: $54MQ3 2024: $85MQ4 2024: --Q1 2025: $50MQ2 2025: โˆ’$70MQ3 2025: $79MQ4 2025: โˆ’$3MQ1 2026: $53MQ2 2026: โˆ’$68MQ3 2026: $26M
QuarterFree cash flowYoY
Q3 2026$26M-67%
Q2 2026-$68.2M+$1.3M
Q1 2026$53.1M+5.9%
Q3 2025$79.3M-7%
Q2 2025-$69.5M-230%
Q1 2025$50.1M+94%
Q3 2024$85.3M+238%
Q2 2024$53.6M+219%

HIMS has the edge over SIGA on cash generation, producing positive trailing cash flow while its opponent burns cash.

SIGA Free Cash Flow

Q4 2023: $79MQ1 2024: โˆ’$6MQ2 2024: $6MQ3 2024: โˆ’$7MQ4 2024: $56MQ1 2025: $7MQ2 2025: $63MQ3 2025: โˆ’$10MQ4 2025: โˆ’$17MQ1 2026: โˆ’$9MQ2 2026: $15MQ3 2026: โˆ’$1M
Q4 2023: $79MQ1 2024: โˆ’$6MQ2 2024: $6MQ3 2024: โˆ’$7MQ4 2024: $56MQ1 2025: $7MQ2 2025: $63MQ3 2025: โˆ’$10MQ4 2025: โˆ’$17MQ1 2026: โˆ’$9MQ2 2026: $15MQ3 2026: โˆ’$1M
QuarterFree cash flowYoY
Q3 2026-$1.2M+$8.9M
Q2 2026$15.2M-76%
Q1 2026-$8.7M-223%
Q4 2025-$16.9M-130%
Q3 2025-$10.1M-$2.7M
Q2 2025$63.1M+960%
Q1 2025$7M+$13.2M
Q4 2024$56.3M-29%

SIGA's free cash flow was โˆ’$12M over the past year, against $116M the year before.

HIMS Total Shares

Q4 2023: 209MQ1 2024: 229MQ2 2024: 235MQ3 2024: 235MQ4 2024: 237MQ1 2025: 247MQ2 2025: 257MQ3 2025: 249MQ4 2025: 258MQ1 2026: 228MQ2 2026: 232MQ3 2026: 234M
Q4 2023: 209MQ1 2024: 229MQ2 2024: 235MQ3 2024: 235MQ4 2024: 237MQ1 2025: 247MQ2 2025: 257MQ3 2025: 249MQ4 2025: 258MQ1 2026: 228MQ2 2026: 232MQ3 2026: 234M
PeriodChange %Net change
Quarterly+0.9%+2.1M shares
1 year-6%-14.9M shares
3 years+11%+23.7M shares
5 years+17%+33.8M shares

HIMS has the edge over SIGA on shareholder dilution, with a more favorable share count trend.

SIGA Total Shares

Q4 2023: 72MQ1 2024: 72MQ2 2024: 72MQ3 2024: 72MQ4 2024: 72MQ1 2025: 71MQ2 2025: 72MQ3 2025: 72MQ4 2025: 72MQ1 2026: 72MQ2 2026: 72MQ3 2026: 72M
Q4 2023: 72MQ1 2024: 72MQ2 2024: 72MQ3 2024: 72MQ4 2024: 72MQ1 2025: 71MQ2 2025: 72MQ3 2025: 72MQ4 2025: 72MQ1 2026: 72MQ2 2026: 72MQ3 2026: 72M
PeriodChange %Net change
Quarterly0%-34.7K shares
1 year+0.3%+244K shares
3 years+1.1%+764K shares
5 years-4%-3M shares
Available history-13%-10.3M shares

SIGA has 72M diluted shares, about the same as a year ago.

HIMS Net Leverage

Q1 2024: -49.8xQ2 2024: -5.5xQ3 2024: -2.9xQ4 2024: -2.8xQ1 2025: -2.1xQ2 2025: -7.3xQ3 2025: -2.2xQ4 2025: -1.4xQ1 2026: -5.9x
Q1 2024: -49.8xQ2 2024: -5.5xQ3 2024: -2.9xQ4 2024: -2.8xQ1 2025: -2.1xQ2 2025: -7.3xQ3 2025: -2.2xQ4 2025: -1.4xQ1 2026: -5.9x
QuarterNet LeverageStatus
Q1 2026-5.9xNet Cash
Q4 2025-1.4xNet Cash
Q3 2025-2.2xNet Cash
Q2 2025-7.3xNet Cash
Q1 2025-2.1xNet Cash
Q4 2024-2.8xNet Cash
Q3 2024-2.9xNet Cash
Q2 2024-5.5xNet Cash

HIMS has more cash than debt.

SIGA Net Leverage

Q4 2023: -1.8xQ1 2024: -1.5xQ2 2024: -1.0xQ3 2024: -0.9xQ4 2024: -2.2xQ1 2025: -2.9xQ2 2025: -1.8xQ3 2025: -1.9xQ4 2025: -6.4xQ1 2026: -6.9x
Q4 2023: -1.8xQ1 2024: -1.5xQ2 2024: -1.0xQ3 2024: -0.9xQ4 2024: -2.2xQ1 2025: -2.9xQ2 2025: -1.8xQ3 2025: -1.9xQ4 2025: -6.4xQ1 2026: -6.9x
QuarterNet LeverageStatus
Q1 2026-6.9xNet Cash
Q4 2025-6.4xNet Cash
Q3 2025-1.9xNet Cash
Q2 2025-1.8xNet Cash
Q1 2025-2.9xNet Cash
Q4 2024-2.2xNet Cash
Q3 2024-0.9xNet Cash
Q2 2024-1.0xNet Cash

SIGA has the edge over HIMS on leverage, with a lower net debt burden relative to earnings.

HIMS Weekly Momentum

MetricValueStatus
RSI36.0Neutral
Stochastic23.0Neutral

HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).

SIGA Weekly Momentum

MetricValueStatus
RSI32.9Neutral
Stochastic21.2Neutral

SIGA's weekly RSI is 33 (neutral) and its Stochastic is 21 (neutral).

HIMS PE vs Healthcare Sector

MetricHIMSSector medianRelative
PEN/A26xโ€”

HIMS has no meaningful PE right now: it lost money over the past year.

SIGA PE vs Healthcare Sector

MetricSIGASector medianRelative
PE289x26x1,018% above
PE %1002971 pts above

SIGA is trading at 289x earnings, a 1018% premium to the Healthcare sector's median of 26x.

HIMS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$27.328% below
20 week MA$29.232% below
50 week MA$27.729% below
100 week MA$35.945% below
200 week MA$24.419% below

HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.

SIGA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.189.1% below
20 week MA$3.2210% below
50 week MA$4.5837% below
100 week MA$5.6649% below
200 week MA$6.0852% below

SIGA is in a downtrend: it's below all five of its weekly moving averages, and 52% below its 200-week average.

HIMS Yearly ROI

YearStart priceEnd priceROI
2020$9.89$15.0+51%
2021$15.0$6.65-56%
2022$6.65$6.43-3.3%
2023$6.43$8.90+38%
2024$8.90$26.6+198%
2025$26.6$34.3+29%
2026 YTD$34.3$19.7-42%

HIMS has the edge over SIGA on returns for 2026, with the stronger performance.

SIGA Yearly ROI

YearStart priceEnd priceROI
2020$4.79$7.34+53%
2021$7.34$7.99+8.9%
2022$7.99$7.76-2.9%
2023$7.76$5.60-28%
2024$5.60$5.93+5.9%
2025$5.93$6.27+5.7%
2026 YTD$6.27$2.89-54%

SIGA is down 54% so far in 2026, after finishing higher in four of the previous six years.

Give your agent the market.

Get API key